Uncovering the misery of devastating diseases through transcriptome and Al modelling
Empowering Rapid and Accurate Medical Assessments through the unveiled Language of Cells for personalized care
Our Aim
Days of only using conventional diagnostic techniques are over. Ayass Research Institute Clinic is bringing the latest technology used by big Pharmaceutical and research companies into daily patient care. Join us as we embark on a new era of medicine in which diagnoses are no longer constrained to superficial observations. Our platform helps medical practitioners make more informed judgments and develop highly individualised treatment regimens for each patient by analysing the complex molecular markers of diseases.
11290-dna-loader
How IT Works
Collection of blood:
We take the blood sample from the patient. Blood samples can provide important details about a person’s health, such as blood cell counts, biochemical markers, the presence or absence of infections, and much more.
Extraction of targeted immune cells:
We isolate PBMC (peripheral blood mononuclear/monocyte cells) from the patient’s blood sample for further study. PBMCs include monocytes and lymphocytes such as T cells, B cells, and natural killer cells. These cells give us valuable information about the patient’s molecular pathways. After profiling the cell types of PBMCs, we determine the cell types that are enriched/activated and isolate them. Total RNA is then extracted for further downstream sequencing and analysis.
Characterization of cells:
Using flow cytometry, the cell populations present within peripheral blood mononuclear cells (PBMCs) are analyzed and characterized based on different cell surface markers and intracellular molecules found in the cells. By staining PBMCs with specific antibodies we can identify and distinguish different subsets of immune cells within PBMCs, such as T cells, B cells, monocytes, natural killer cells, etc.
Next-generation RNA sequencing:
Next-generation RNA sequencing (RNA-seq) is a powerful high-throughput sequencing technology used to analyze the transcriptome that allows us to detect and quantify RNA molecules in a sample in a comprehensive and unbiased manner. Our technology is targeted against 18,000 mRNAs.
Bioinformatics analysis:
After generating a substantial volume of sequencing data, we employ an in-house bioinformatics pipeline, which relies on online libraries and databases. This pipeline aids in the interpretation of molecular data, enabling us to decipher gene-specific information and subsequently identify diseases. Moreover, it facilitates further molecular analysis for a comprehensive understanding of the underlying mechanisms.
Disease pathways characterization:
By harnessing the molecular insights obtained through transcriptome analysis, precise diagnoses can be made, and potential treatment options can be explored. This approach enables the identification of specific diseases or conditions that may be affecting the patient.
More accurate characterisation
Molecular analysis plays a vital role in achieving more precise disease characterization by revealing information regarding gene expression patterns that are associated with specific diseases.
More accurate characterisation
Molecular analysis plays a vital role in achieving more precise disease characterization by revealing information regarding gene expression patterns that are associated with specific diseases.
Better scoring of disease activity and severity
While evaluating disease severity using molecular analysis, gene expression profiles, and clinical data are used to specify a quantitative disease severity analysis, enhancing the scoring process.
Better scoring of disease activity and severity
While evaluating disease severity using molecular analysis, gene expression profiles, and clinical data are used to specify a quantitative disease severity analysis, enhancing the scoring process.
Better precision treatment option
The molecular analysis tools hold the potential to identify possible therapeutic targets and provide better treatment options by presenting valuable insights into the molecular alterations that might be the cause of certain diseases.
Better precision treatment option
The molecular analysis tools hold the potential to identify possible therapeutic targets and provide better treatment options by presenting valuable insights into the molecular alterations that might be the cause of certain diseases.
Better treatment monitoring
By recording therapy responses, predicting outcomes, monitoring resistance, and identifying potential targets, molecular analysis can lead to personalized treatment options, which enhances patient care.
Better treatment monitoring
By recording therapy responses, predicting outcomes, monitoring resistance, and identifying potential targets, molecular analysis can lead to personalized treatment options, which enhances patient care.
Prevention of drug-induced toxicities
Molecular analysis offers a vast view of gene expression changes associated with drug toxicities, thus helping in the prevention of adverse drug reactions.
Prevention of drug-induced toxicities
Molecular analysis offers a vast view of gene expression changes associated with drug toxicities, thus helping in the prevention of adverse drug reactions.
Exploring the Dynamics
The study of a transcriptome provides extensive knowledge regarding the expression, control, and function of DNA.
Why choose us?
Our high-quality services, which combine molecular science, modern technology, and an abundance of medical knowledge, are created to revolutionize how healthcare practitioners identify, diagnose, and prevent diseases. Explore the latest innovations to their full potential with our Disease Diagnosis Solutions.
Why choose us?
Our high-quality services, which combine molecular science, modern technology, and an abundance of medical knowledge, are created to revolutionize how healthcare practitioners identify, diagnose, and prevent diseases. Explore the latest innovations to their full potential with our Disease Diagnosis Solutions.
How are we different from other clinics?
We work on a molecular level to diagnose and predict the severity of the disease. Our high-quality labs equipped with advanced technology enable us to study the transcriptome of the patient.
Our in-house bioinformatics tool enhances the accuracy of diagnoses, enables personalized treatment approaches, facilitates the discovery of new biomarkers and therapeutic targets, and contributes to evidence-based decision-making for improved patient outcomes and precision medicine.
How are we different from other clinics?
We work on a molecular level to diagnose and predict the severity of the disease. Our high-quality labs equipped with advanced technology enable us to study the transcriptome of the patient.
Our in-house bioinformatics tool enhances the accuracy of diagnoses, enables personalized treatment approaches, facilitates the discovery of new biomarkers and therapeutic targets, and contributes to evidence-based decision-making for improved patient outcomes and precision medicine.
What we offer?
Our clinic offers a holistic perspective of a patient's health by analyzing the complex network of molecular interactions within the body, allowing our medical experts to spot diseases in the very early stages when intervention is most successful. Early disease identification is now a potent weapon in the fight against diseases.
What we offer?
Our clinic offers a holistic perspective of a patient's health by analyzing the complex network of molecular interactions within the body, allowing our medical experts to spot diseases in the very early stages when intervention is most successful. Early disease identification is now a potent weapon in the fight against diseases.
Join Our Newsletter!
Take Your First Step Towards Wellness
